Menopause and modifiable coronary heart disease risk factors: A population based study

Maturitas

Volumn 65, Issue 3, 2010, Pages 237-243

  Agrinier, N ^a,f   Cournot, M ^b   Dallongeville, J ^c   Arveiler, D ^d   Ducimetiere P ^e   Ruidavets, J B ^e   Ferrieres J ^e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Centre Hospitalier du Val d'Ariege   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Coronary heart disease risk factors; Epidemiology; Lipids; Menopause

Indexed keywords

CHOLESTEROL; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MENOPAUSE; OUTCOME ASSESSMENT; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRANCE; HUMANS; MENOPAUSE; MIDDLE AGED; RISK FACTORS;

EID: 76349108275     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.11.023     Document Type: Article

References (41)

1. Artaud-Wild S.M., Connor S.L., Sexton G., and Connor W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88 December (6) (1993) 2771-2779
2. Dallongeville J., Marecaux N., Isorez D., Zylbergberg G., Fruchart J.C., and Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 118 November (1) (1995) 123-133
3. Schaefer E.J., Lamon-Fava S., Cohn S.D., et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35 May (5) (1994) 779-792
4. Tremollieres F.A., Pouilles J.M., Cauneille C., and Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 142 February (2) (1999) 415-423
5. Fukami K., Koike K., Hirota K., Yoshikawa H., and Miyake A. Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study. Maturitas 22 November (3) (1995) 193-197
6. Lindquist O. Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in Goteborg, Sweden. Prev Med 11 March (2) (1982) 162-172
7. Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., and Wing R.R. Menopause and risk factors for coronary heart disease. N Engl J Med 321 September (10) (1989) 641-646
8. Menotti A., Keys A., Kromhout D., et al. Inter-cohort differences in coronary heart disease mortality in the 25-year follow-up of the seven countries study. Eur J Epidemiol 9 September (5) (1993) 527-536
9. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., and Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 July (1) (1994) 583-612
10. Masia R., Pena A., Marrugat J., et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR investigators. J Epidemiol Community Health 52 November (11) (1998) 707-715
11. Kromhout D., Menotti A., Bloemberg B., et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 24 May (3) (1995) 308-315
12. Rozenbaum H. La Ménopause. Conférence Européenne de Consensus. Eska ed. Paris 1; 1995.
13. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., and Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353 May (9164) (1999) 1547-1557
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 June (6) (1972) 499-502
15. Anderson K.M., Wilson P.W., Odell P.M., and Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 83 January (1) (1991) 356-362
16. Merz C.N., Kelsey S.F., Pepine C.J., et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 33 May (6) (1999) 1453-1461
17. Guide National de Prescription des médicaments. 6° ed. Paris 1; 1994.
18. Rogan J.C., and Keselman H.J. Is the ANOVA F-test robust to variance heterogeneity when sample sizes are equals?: an investigation via coefficient of variation. Am Educ Res J 14 4 (1977) 493-498
19. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 6 (1979) 65-70
20. Royston P., and Altman D.G. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Appl Stat 43 3 (1994) 429-467
21. Stamler J., Wentworth D., and Neaton J.D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256 November (20) (1986) 2823-2828
22. Chen Z., Peto R., Collins R., MacMahon S., Lu J., and Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 303 August (6797) (1991) 276-282
23. Peters H.W., Westendorp I.C., Hak A.E., et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med 246 December (6) (1999) 521-528
24. Pasquali R., Casimirri F., Pascal G., et al. Influence of menopause on blood cholesterol levels in women: the role of body composition, fat distribution and hormonal milieu. Virgilio Menopause Health Group. J Intern Med 241 March (3) (1997) 195-203
25. Torng P.L., Su T.C., Sung F.C., et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight-the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 161 April (2) (2002) 409-415
26. Akahoshi M., Soda M., Nakashima E., Shimaoka K., Seto S., and Yano K. Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation 94 July (1) (1996) 61-66
27. Walsh B.W., Schiff I., Rosner B., Greenberg L., Ravnikar V., and Sacks F.M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325 October (17) (1991) 1196-1204
28. Messa C., Notarnicola M., Russo F., et al. Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. Scand J Gastroenterol 40 December (12) (2005) 1454-1461
29. Everson G.T., McKinley C., and Kern Jr. F. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 87 January (1) (1991) 237-246
30. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 July (2) (2001) 180-187
31. Brindle P., Emberson J., Lampe F., et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327 November (7426) (2003) 1267
32. Empana J.P., Ducimetiere P., Arveiler D., et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 24 November (21) (2003) 1903-1911
33. Hense H.W., Schulte H., Lowel H., Assmann G., and Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 24 May (10) (2003) 937-945
34. Grodstein F., and Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38 November-December (3) (1995) 199-210
35. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 273 January (3) (1995) 199-208
36. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 August (7) (1998) 605-613
37. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 July (3) (2002) 321-333
38. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA 288 August (7) (2002) 872-881
39. Traitements hormonaux substitutifs de la ménopause. Paris: AFSSAPS ANAES INSERM; 2004 05/11/2004.
40. Stampfer M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20 January (1) (1991) 47-63
41. Agence Nationale pour le Développement de l'Evaluation Médicale. Hypolipidémiants Recommandations et références médicales. Concours Med. 1996;Sect. 58-72.